In  this role, the office is responsible for (1) developing a national drug  control policy, (2) developing and applying specific goals and  performance measurements to evaluate the effectiveness of national drug  control policy and National Drug Control Program agencies’ programs,  (3) overseeing and coordinating the implementation of the national drug  control policy, and (4) assessing and certifying the adequacy of the  budget for National Drug Control Programs. Also, from fiscal year 1991 to  fiscal year 2011, ONDCP managed the Counterdrug Technology  Assessment Center (CTAC). In March 2013, we reported that ONDCP and the federal agencies lacked  progress on achieving the Strategy goals and were in the process of  implementing a new mechanism to monitor progress. As we reported in  May 2016, ONDCP and the federal agencies had made moderate  progress toward achieving one goal, limited progress on three goals, and  no demonstrated progress on the remaining three goals. In many instances,  the data used to assess progress, while the most up to date at the time,  were several years old. Based on the most recent data available,  although some of the sub-measures, such as decreasing tobacco use by  eighth graders, were achieved, none of the seven overall goals in the  Strategy have been fully achieved as of July 2017. Table 1 shows the  2010 Strategy goals and progress toward meeting them as of July 2017. For example:
Progress was made on the goal to decrease the 30-day prevalence of  drug use among 12- to 17-year-olds by 15 percent. The rates of reported marijuana use for this  measure increased by 9 percent from 2009 to 2015. For example:
Progress was not made on the goal to reduce drug-induced deaths by  15 percent. Themes from a Comptroller General Forum on Preventing Illicit Drug Use

To advance the national dialogue on preventing illicit drug use, including  preventing individuals from using illicit drugs for the first time, we  convened and moderated a diverse panel of health care, education, and  law enforcement experts, including from ONDCP, on June 22, 2016. The  panel focused on (1) common factors related to illicit drug use; (2)  strategies in the education, health care, and law enforcement sectors to  prevent illicit drug use; and (3) high priority areas for future action to  prevent illicit drug use, and our November 2016 report summarized the  themes from the forum. Forum participants also noted several strategies available in the  education, health care, and law enforcement sectors for preventing illicit  drug use:
Education. Forum participants championed the use of school-or  community-based prevention programs that research has shown to be  successful in preventing illicit drug use and other behaviors. Forum participants also identified several high priority areas for future  action to help prevent illicit drug use, including the misuse of prescription  drugs. Some examples include:  supporting community coalitions comprising the health care,  education, and law enforcement sectors that work in concert to  prevent illicit drug use at the local level;  consolidating federal funding streams for multiple prevention  programs into a single fund used to address the risk factors for a  range of unhealthy behaviors, including illicit drug use;  increasing the use of prevention programs that research has shown to  be effective, such as those that are well-designed and deliver  persuasive drug prevention messages on a regular basis;  identifying and pursuing ways to change perceptions of substance  abuse disorders and illicit drug use, such as emphasizing that a  substance abuse disorder is a disease of the brain and can be treated  like other diseases;  supporting drug prevention efforts in primary care settings, such as  exploring ways to reimburse providers for conducting preventative  drug screenings; and  reducing the number of prescriptions issued for opioids. Agencies Have Strengthened Collaboration of Drug- Free Communities Support Program but Could Enhance Grantee Compliance and Performance Monitoring

In February 2017, we issued a report on the Drug-Free Communities  Support Program (DFC)—a program that ONDCP and SAMHSA jointly  manage. This program aims to support drug abuse prevention efforts that  engage schools, law enforcement, and other sectors of a community to  target reductions in the use of alcohol, tobacco, marijuana, and the illicit  use of prescription drugs. In our February 2017 report, we found that ONDCP and  SAMHSA had improved their joint management of the program. We made recommendations that SAMHSA develop an action plan to  strengthen the agency’s grant monitoring process and ensure ONDCP  gets complete and accurate information, among other things. SAMHSA  concurred with our recommendations and reported to us in April 2017 that  it is implementing actions to address our recommendations that should be  completed by this fall.
Why GAO Did This Study

According to the National Institute on Drug Abuse, in 2015, the most recent year for which national data are available, over 52,000 Americans died from drug overdoses, or approximately 144 people every day. Policymakers, criminal justice officials, health care providers, and the public at large are turning with renewed attention to the drug epidemic and its impact on our nation. To help reduce illicit drug use and its consequences, ONDCP oversees and coordinates the implementation of national drug control policy across the federal government.
This statement addresses: (1) the federal government's progress in achieving Strategy goals, (2) results from a Comptroller General's Forum on preventing illicit drug use, and (3) the findings of GAO's recent review of ONDCP's DFC Support program.
This statement is based on GAO's prior work issued from May 2016 through February 2017, with selected status updates as of July 2017, and updates from ONDCP's National Drug Control Budget Funding Highlight reports issued from fiscal year 2016 to fiscal year 2018. For the updates, GAO used publically available data sources that ONDCP uses to assess its progress on Strategy goals, and interviewed ONDCP officials.

What GAO Found

The federal government has made mixed progress toward achieving the goals articulated in the 2010 National Drug Control Strategy (Strategy). In the Strategy, the Office of National Drug Control Policy (ONDCP) established seven goals related to reducing illicit drug use and its consequences by 2015. In many instances, the data used to assess progress in 2015 have only recently become available. GAO's review of this updated data indicates that, as of July 2017, the federal government made moderate progress toward achieving two goals, limited progress on two goals, and no progress on the other three goals. However, none of the overall goals in the Strategy were fully achieved. For example, progress had not been made on the goal to reduce drug-induced deaths by 15 percent. Drug-induced deaths instead increased from 2009 to 2015 by 41.5 percent. Although progress was made reducing the 30-day prevalence of drug use among 12- to 17-year-olds from the 10.1 percent reported in 2009, the goal of reducing prevalence to 8.6 percent by 2015 was not achieved. According to ONDCP, as of July 2017, work is currently underway to develop a new strategy.
In June 2016, GAO convened a diverse panel of experts, including from ONDCP to advance the national dialogue on preventing illicit drug use. The panel focused on (1) common factors related to illicit drug use; (2) strategies in the education, health care, and law enforcement sectors to prevent illicit drug use; and (3) high priority areas for future action to prevent illicit drug use. According to forum participants, illicit drug use typically occurs for the first time in adolescence, involves marijuana, and increasingly, legal prescriptions for opioid-based pain relievers. Forum participants also discussed strategies available in the education, health care, and law enforcement sectors for preventing illicit drug use. For example, forum participants championed the use of school- or-community-based prevention programs that research has shown to be successful in preventing illicit drug use and other behaviors. They also identified several high priority areas for future actions to prevent illicit drug use, including: supporting community coalitions, consolidating federal funding streams for prevention programs, and reducing the number of opioid prescriptions.
In February 2017, GAO issued a report on the Drug-Free Communities Support Program (DFC)—a program that ONDCP and the Substance Abuse and Mental Health Services Administration (SAMHSA) jointly manage. This program aims to support drug abuse prevention efforts that engage schools, law enforcement, and other sectors of a community to target reductions in the use of alcohol, tobacco, marijuana, and the illicit use of prescription drugs. GAO reported that ONDCP and SAMHSA had strengthened their joint management of the program by employing leading collaboration practices; however, the agencies could enhance DFC grantee compliance and performance monitoring. For example, SAMHSA did not consistently confirm grantees had completed plans to achieve long-term goals after exiting the program. GAO recommended that SAMHSA develop an action plan to strengthen DFC grant monitoring and ensure it sends complete and accurate information to ONDCP. SAMHSA concurred with GAO's recommendations and reported in April 2017 that its actions to address them should be completed by this fall.